Ubiquitin specific peptidases as redox sensor in oncogene-induced p53 signaling
Ubiquitin specific peptidases as redox sensor in oncogene-induced p53 signaling
批准号:
9015747
负责人:
Xiongbin Lu
金额:
$0.61万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-03-01 至 2017-06-14
关键词:
Biological ProcessBreast Cancer ModelBreast Epithelial CellsCHEK1 geneCHEK2 geneCellsCysteineDNA DamageDeubiquitinationEventExhibitsExpression LibraryGoalsHealthMalignant - descriptorMalignant NeoplasmsMediatingMetabolicMitochondriaMolecularOncogene ActivationOncogenesOncogenicOxidation-ReductionPathway interactionsPeptide HydrolasesPhosphorylationPhysiologicalPlayPremalignant CellProtein KinaseProtein p53ProteinsReactive Oxygen SpeciesRegulationRoleSerineSignal TransductionSiteStressTP53 geneThreonineTranslatingUbiquitinUbiquitinationbasecDNA Librarycancer initiationgenome-wide analysisinhibitor/antagonistmutantnoveloxidationprotein degradationresponsesenescencesensortumor initiationubiquitin-protein ligase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Oncogene-induced senescence (OIS) is a major anti-cancer barrier that inhibits malignant transformation of precancerous cells, in which the p53 signaling plays a central role. Previous studies have shown that p53 induction in precancerous cells is attributed to the ATM-mediated DNA damage response (DDR). Several protein kinases in the DDR, including ATM, CHK1 and CHK2, phosphorylate p53 at multiple serine/threonine sites, which has long been considered to stabilize and activate p53. However, we and other groups found that phosphorylation-deficient p53 mutant exhibited similar protein stability as the wildtype p53, suggesting that DDR-induced phosphorylation events may not be the only major factor for the p53 induction in response to oncogenic stress. The goal of this application is to unravel the oncogene-induced p53 response in mechanistic detail. P53 is tightly controlled at physiological levels by ubiquitination-mediated protein degradation. Much has been studied on the p53-targeting E3 ubiquitin ligases, such as Mdm2, ARF-BP1, and COP1, little is known about the deubiquitination of p53. In a genome-wide screen using a cDNA library of ubiquitin specific peptidases (USPs), we searched for potential USPs for p53 deubiquitination. Intriguingly, as many as 16 USPs significantly inhibited p53, while only 4 USPs moderately increased p53 activity. This result indicated that USPs probably modulate p53 activity primarily through promoting p53 inhibitors, such as E3 ubiquitin ligases. Since all of the p53-targeting E3 ubiquitin ligases are also degraded by auto-ubiquitination, a potential mechanism is that USPs negatively regulate p53 levels via deubiquitination and stabilization of the p53- targeting E3 ligases. This is true in the previously identified USP7-Mdm2-p53 regulatory loop, and is also supported by our current finding that USP4 inhibits p53 by deubiquitination and stabilization of ARF-BP1. Furthermore, p53 is induced upon oncogenic stress even in the absence of detectable DNA damage, suggesting a DDR-independent induction of p53. In this study, we show that oncogene-induced reactive oxygen species (ROS) inactivate the enzymatic activity of USPs through oxidation of crucial cysteine residues in their catalytic pockets, resulting in destabilization of the p53-targeting E3 ligases and consequential stabilization of p53. Based on these results, we propose that USPs function as redox sensor to translate oncogenic stress into the p53 signaling during cancer initiation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting FOXP3 mRNA splicing for breast cancer immunotherapy
-
批准号:10717185
-
项目类别:
-
资助金额:$58.52万
-
财政年份:2023
-
负责人:Xiongbin Lu
-
依托单位:
Targeting immunoproteasome-mediated antigen presentation in colorectal cancer immunotherapy
-
批准号:10385926
-
项目类别:
-
资助金额:$50.18万
-
财政年份:2022
-
负责人:Xiongbin Lu
-
依托单位:
Targeting immunoproteasome-mediated antigen presentation in colorectal cancer immunotherapy
-
批准号:10545058
-
项目类别:
-
资助金额:$49.18万
-
财政年份:2022
-
负责人:Xiongbin Lu
-
依托单位:
Identification of USP13 as a therapeutic target for ovarian cancer
-
批准号:10328885
-
项目类别:
-
资助金额:$34.75万
-
财政年份:2018
-
负责人:Xiongbin Lu
-
依托单位:
Identification of USP13 as a therapeutic target for ovarian cancer
-
批准号:10092972
-
项目类别:
-
资助金额:$35.75万
-
财政年份:2018
-
负责人:Xiongbin Lu
-
依托单位:
Targeting Human Cancers with Hemizygous Deletion of TP53
-
批准号:9891965
-
项目类别:
-
资助金额:$36.03万
-
财政年份:2017
-
负责人:Xiongbin Lu
-
依托单位:
Targeting HER2-low breast cancer with 17p loss
-
批准号:10203209
-
项目类别:
-
资助金额:$53.54万
-
财政年份:2016
-
负责人:Xiongbin Lu
-
依托单位:
Targeting HER2-low breast cancer with 17p loss
-
批准号:10615742
-
项目类别:
-
资助金额:$52.47万
-
财政年份:2016
-
负责人:Xiongbin Lu
-
依托单位:
Targeting HER2-low breast cancer with 17p loss
-
批准号:10399601
-
项目类别:
-
资助金额:$52.47万
-
财政年份:2016
-
负责人:Xiongbin Lu
-
依托单位:
Targeting Human Cancers with Hemizygous Deletion of TP53
-
批准号:9074698
-
项目类别:
-
资助金额:$36.6万
-
财政年份:2016
-
负责人:Xiongbin Lu
-
依托单位:
ROLE OF PROTEIN PHOSPHATASES IN THE DNA DAMAGE RESPONSE
-
批准号:8360353
-
项目类别:
-
资助金额:$3.54万
-
财政年份:2011
-
负责人:Xiongbin Lu
-
依托单位:
ROLE OF PROTEIN PHOSPHATASES IN THE DNA DAMAGE RESPONSE
-
批准号:8167873
-
项目类别:
-
资助金额:$14.22万
-
财政年份:2010
-
负责人:Xiongbin Lu
-
依托单位:
Identification of Novel Protein Phosphatases in the ATM Signaling Pathway
-
批准号:8224187
-
项目类别:
-
资助金额:$4.78万
-
财政年份:2009
-
负责人:Xiongbin Lu
-
依托单位:
Regulation of the ATM/ATR-p53 DNA Damage Signaling Pathway by the Wip1 Phosphatas
-
批准号:8230806
-
项目类别:
-
资助金额:$31.8万
-
财政年份:2009
-
负责人:Xiongbin Lu
-
依托单位:
Identification of Novel Protein Phosphatases in the ATM Signaling Pathway
-
批准号:7762036
-
项目类别:
-
资助金额:$6.98万
-
财政年份:2009
-
负责人:Xiongbin Lu
-
依托单位:
Regulation of the ATM/ATR-p53 DNA Damage Signaling Pathway by the Wip1 Phosphatas
-
批准号:7660999
-
项目类别:
-
资助金额:$29.88万
-
财政年份:2009
-
负责人:Xiongbin Lu
-
依托单位:
Regulation of the ATM/ATR-p53 DNA Damage Signaling Pathway by the Wip1 Phosphatas
-
批准号:8038452
-
项目类别:
-
资助金额:$31.8万
-
财政年份:2009
-
负责人:Xiongbin Lu
-
依托单位:
Identification of Novel Protein Phosphatases in the ATM Signaling Pathway
-
批准号:7941711
-
项目类别:
-
资助金额:$2.59万
-
财政年份:2009
-
负责人:Xiongbin Lu
-
依托单位:
Regulation of the ATM/ATR-p53 DNA Damage Signaling Pathway by the Wip1 Phosphatas
-
批准号:8444681
-
项目类别:
-
资助金额:$29.89万
-
财政年份:2009
-
负责人:Xiongbin Lu
-
依托单位:
海外基金